Enzyvant Announces First-Ever Data on Burden of Illness and Costs of Supportive Care for Pediatric Congenital Athymia

NEXT STORY
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
PREV STORY
Global Medical Drainage Consumables Market Report 2021-2024
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Enzyvant Announces First-Ever Data on Burden of Illness and Costs of Supportive Care for Pediatric Congenital Athymia

NEXT STORY
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
PREV STORY
Global Medical Drainage Consumables Market Report 2021-2024
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clementia Pharmaceuticals to Participate in Upcoming Investor Conferences

MONTREAL, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical stage ...

author_avatar
NASDAQ Market News

Immune Design Announces Program Updates & Portfolio Prioritization for G100 and CMB305

G100 development to accelerate in follicular lymphoma and beyondCMB305 to be deprioritized to support ...

author_avatar
NASDAQ Market News

Aravax to Present PVX108 Phase 1 Clinical Trial Results at AAAAI 2019 Annual Meeting

Study designed to evaluate safety and tolerability of a novel peptide-based immunotherapy to treat ...

author_avatar
NASDAQ Market News